Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,675 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study.
Shim SH, Yang EJ, Jang EB, Lee S, Kim HS, Shin YK, Lee SW, Chang CS, Song H, Lee SJ, Kim J, Chang SJ, Lim MC, Choi CH. Shim SH, et al. Among authors: lee sw, lee sj, lee s. Int J Gynaecol Obstet. 2024 Apr 29. doi: 10.1002/ijgo.15533. Online ahead of print. Int J Gynaecol Obstet. 2024. PMID: 38682391
Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
Lee AJ, Yang EJ, Kim NK, Kim Y, Suh DH, Kim J, Son JH, Kong TW, Chang SJ, Hwang DW, Park SJ, Kim HS, Yoo JG, Lee SJ, Lee YY, Shim SH. Lee AJ, et al. Among authors: lee sj, lee yy. Gynecol Oncol. 2023 Jul;174:106-113. doi: 10.1016/j.ygyno.2023.04.027. Epub 2023 May 10. Gynecol Oncol. 2023. PMID: 37172410
Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).
Kong TW, Kim J, Son JH, Lee AJ, Yang EJ, Shim SH, Kim NK, Kim Y, Suh DH, Hwang DW, Park SJ, Kim HS, Lee YY, Yoo JG, Lee SJ, Chang SJ. Kong TW, et al. Among authors: lee sj, lee aj, lee yy. Gynecol Oncol. 2023 Sep;176:122-129. doi: 10.1016/j.ygyno.2023.07.009. Epub 2023 Jul 27. Gynecol Oncol. 2023. PMID: 37515926
Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).
Kim NK, Kim Y, Kim HS, Park SJ, Hwang DW, Lee SJ, Yoo JG, Chang SJ, Son JH, Kong TW, Kim J, Shim SH, Lee AJ, Suh DH, Lee YY. Kim NK, et al. Among authors: lee sj, lee aj, lee yy. Cancer Med. 2023 Oct;12(19):19449-19459. doi: 10.1002/cam4.6546. Epub 2023 Sep 28. Cancer Med. 2023. PMID: 37768030 Free PMC article.
Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial.
Park SJ, Shim SH, Ji YI, Kwon SH, Lee EJ, Lee M, Chang SJ, Park S, Kim SY, Lee SJ, Kim JW, Roh JW, Lee SH, Song T, Kim HS. Park SJ, et al. Among authors: lee ej, lee sh, lee sj, lee m. BMC Cancer. 2020 May 6;20(1):385. doi: 10.1186/s12885-020-06886-2. BMC Cancer. 2020. PMID: 32375688 Free PMC article. Clinical Trial.
Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
Park SJ, Kong TW, Kim T, Lee M, Choi CH, Shim SH, Yim GW, Lee S, Lee EJ, Lim MC, Chang SJ, Lee SJ, Lee SH, Song T, Lee YY, Kim HS, Nam EJ. Park SJ, et al. Among authors: lee ej, lee sh, lee sj, lee m, lee yy, lee s. BMC Cancer. 2022 Mar 26;22(1):331. doi: 10.1186/s12885-022-09429-z. BMC Cancer. 2022. PMID: 35346103 Free PMC article.
12,675 results
You have reached the last available page of results. Please see the User Guide for more information.